Bipolar Disorder Trial, Recruiting NCT06188754 Sponsor: University of California, Berkeley Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06188754
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Bipolar I or Bipolar II disorder (not cyclothymia or other related conditions)
  • You are currently experiencing sleep problems, such as trouble sleeping, sleeping too much, or issues with your body clock (like going to sleep very late or at irregular times)
  • You live in an English-speaking country and have spoken English for at least 10 years, speak English at home, or can demonstrate you understand English well
  • You are currently receiving medical care for your bipolar disorder (the trial will help connect you with care if needed)
  • Your bipolar medications have not changed in the past month
  • Your weight has not changed by more than about 11 pounds (5 kg) in the past 3 months
  • You currently eat across a period of 12 hours or more on at least two days per week
  • You are able to use a smartphone camera and complete online surveys (a phone can be loaned to you if needed)
  • You do not work night shifts and do not have responsibilities that regularly disrupt your sleep between 10pm and 5am more than once a week
  • You are able to keep a food diary for 7 days, logging meals at least twice a day
  • You are able to complete online questionnaires carefully and attentively

Who may not be able to join:

  • You are currently going through an episode of depression, hypomania, mania, or psychosis
  • You have ever been diagnosed with or treated for an eating disorder, or your answers to eating-related screening questions suggest a possible concern
  • You have had an alcohol or drug use disorder in the past 3 months
  • You are currently having serious thoughts of suicide along with a plan, intent, or history of attempts
  • You are pregnant or breastfeeding
  • You have an uncorrected thyroid condition, or a digestive condition that affects how your body absorbs nutrients
  • You have certain medical conditions such as HIV, AIDS, lupus, or multiple sclerosis (confirm with trial site)
  • You take certain medications that are not compatible with fasting, including clozapine, diabetes medications, blood sugar-lowering injections, corticosteroids, or medications that must be taken with food at specific times (confirm with trial site for your specific medication)
  • You have significant memory or thinking difficulties, as assessed during the screening interview

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheri L Johnson, PhD, University of California, Berkeley

Phone: (510) 519-4305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of California, Berkeley
Registry
ClinicalTrials.gov
Start date
5 June 2024
Est. completion
28 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability; Adherence to time-restricted eating; Adherence to Mediterranean Diet; Mania; Depression; Self-rated Quality of Life (QOL); Mania at follow-up; Depression at follow-up; QOL at follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov